Literature DB >> 18974490

Increased prevalence of extended spectrum beta lactamase producers in neonatal septicaemic cases at a tertiary referral hospital.

A Bhattacharjee1, M R Sen, P Prakash, A Gaur, S Anupurba.   

Abstract

Emergence of extended spectrum beta lactamases (ESBLs) producing strains of gram negative bacteria, as one of the leading cause of septicaemia often complicates the clinical and therapeutic outcome. The present study was undertaken to investigate the prevalence of ESBLs in bacteria isolated from neonatal septicaemic cases along with their antimicrobial sensitivity pattern. Blood samples were collected from 243 suspected cases of neonatal septicaemia. Apart from susceptibility testing, all the gram negative isolates were subjected to phenotypic tests for ESBL production. Amongst the positive test samples (n = 115), 84 were gram negative rods. ESBL was detected in 26 (32%) isolates. Results indicate that routine ESBL detection should be made imperative and empirical use of third generation cephalosporins must be discouraged.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18974490     DOI: 10.4103/0255-0857.43578

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  18 in total

1.  Co-production of ESBL and AmpC β-Lactamases in Clinical Isolates of A. baumannii and A. lwoffii in a Tertiary Care Hospital From Northern India.

Authors:  Pooja Singla; Rama Sikka; Antariksh Deeep; Deep Gagneja; Uma Chaudhary
Journal:  J Clin Diagn Res       Date:  2014-04-15

2.  Neonatal sepsis.

Authors:  Chand Wattal; J K Oberoi
Journal:  Indian J Pediatr       Date:  2011-03-12       Impact factor: 1.967

3.  Extended-spectrum-β-lactamase-producing Escherichia coli isolate possessing the Shiga toxin gene (stx1) belonging to the O64 serogroup associated with human disease in India.

Authors:  T K Dutta; Iadarilin Warjri; P Roychoudhury; H Lalzampuia; I Samanta; S N Joardar; S Bandyopadhyay; Rajesh Chandra
Journal:  J Clin Microbiol       Date:  2013-04-10       Impact factor: 5.948

4.  Isolation of MRSA, ESBL and AmpC - β -lactamases from Neonatal Sepsis at a Tertiary Care Hospital.

Authors:  Amutha Chelliah; Ravinder Thyagarajan; Radhika Katragadda; K V Leela; R Narayana Babu
Journal:  J Clin Diagn Res       Date:  2014-06-20

5.  "Neonatal Sepsis": Bacteria & their Susceptibility Pattern towards Antibiotics in Neonatal Intensive Care Unit.

Authors:  Chandra Madhur Sharma; Ravi Prakash Agrawal; Hariom Sharan; Bijay Kumar; Deepti Sharma; Santokh Singh Bhatia
Journal:  J Clin Diagn Res       Date:  2013-09-30

6.  Analysis of ESBL- and AmpC-positive Enterobacteriaceae at the Department of Neonatology, University Hospital Olomouc.

Authors:  Vendula Husičková; Magdaléna Chromá; Milan Kolář; Kristýna Hricová; Taťána Stosová; Lumír Kantor; Lubomír Dubrava
Journal:  Curr Microbiol       Date:  2011-03-13       Impact factor: 2.188

7.  ESBL-producing Shiga-toxigenic E. coli (STEC) associated with piglet diarrhoea in India.

Authors:  Rajkumari Mandakini; Tapan Kumar Dutta; Santhalembi Chingtham; Parimal Roychoudhury; Indranil Samanta; Sidhartha Narayan Joardar; Abigail R Pachauau; Rajesh Chandra
Journal:  Trop Anim Health Prod       Date:  2014-12-04       Impact factor: 1.559

8.  Staphylococcus aureus- the predominant pathogen in the neonatal ICU of a tertiary care hospital in amritsar, India.

Authors:  Poonam Sharma; Parminder Kaur; Aruna Aggarwal
Journal:  J Clin Diagn Res       Date:  2012-11-02

9.  Metallo-beta-lactamase Producing Pseudomonas aeruginosa in Neonatal Septicemia.

Authors:  Madhu Sharma; Sarita Yadav; Uma Chaudhary
Journal:  J Lab Physicians       Date:  2010-01

10.  Subtyping β-lactamase-producing Escherichia coli strains isolated from patients with UTI by MLVA and PFGE methods.

Authors:  Alireza Dolatyar Dehkharghani; Setareh Haghighat; Marjan Rahnamaye Farzami; Masoumeh Douraghi; Mohammad Rahbar
Journal:  Iran J Basic Med Sci       Date:  2021-04       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.